Observational study of the recent efficacy and economy of itraconazole vs. voriconazole in perioperative pulmonary aspergillosis
BackgroundAntifungal therapy is a common treatment option for pulmonary aspergillosis, but its use to prevent recurrence and relieve symptoms in patients with pulmonary aspergillosis remains controversial. This study aimed to explore the short-term efficacy and cost of itraconazole vs. voriconazole...
Saved in:
| Main Authors: | Peng Chen, Xiao Zhang, Xinzhe Zheng, Yang Tang, Yongxiang Song, Gang Xu, Xixian Ke, Cheng Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1553699/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01) -
Efficacy of Azole Derivatives, Clotrimazole, Itraconazole, and Voriconazole on Cystic Echinococcosis protoscolices: A Comparative Study
by: Ali Pouryousef, et al.
Published: (2025-03-01) -
Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis
by: Pinar Bakir Ekinci, et al.
Published: (2024-10-01) -
Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China
by: Zhuo Li, et al.
Published: (2025-05-01) -
Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study
by: Gianfranco Schiraldi, et al.
Published: (2016-03-01)